Radhika Korupolu

This inventor holds 21 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Rani Therapeutics, LLC, Incube Labs, LLC. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Radhika Korupolu. Retrieved from https://idiyas.com/inventor/radhika-korupolu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 10)

% Patents Active = 95.2

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 4.9

ph-index = 10

Forward Citations = 187(Granted Patents)

Location History:

San Jose, CA (US) (2015 - 2023)
Fremont, CA (US) (2018 - 2024)

Company Filing History:

11 out of 97

Rani Therapeutics, LLC

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Polypeptides

Antibodies

Transdermal Delivery

Clotting Factor

Iontophoresis

Drug Delivery Device

Therapeutic Agents

Solid Masses

TNF-Inhibiting

PCSK9

Exenatide

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12214019 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2025-02-04),

2. 12201721 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2025-01-21),

3. 12018090 - PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2024-06-25),

4. 11826464 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2023-11-28),

5. 11718665 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2023-08-08),

6. 11548940 - Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2023-01-10),

7. 11464737 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2022-10-11),

8. 11304993 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2022-04-19),

9. 11291709 - Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies (2022-04-05),

10. 11026998 - Shaped mass composition comprising exenatide (2021-06-08),

11. 10953075 - Pharmaceutical compositions and methods for fabrication of solid masses comprising anti-interleukin antibodies (2021-03-23),

12. 10780266 - System and method for biphasic transdermal iontophoretic therapeutic agents (2020-09-22),

13. 10689460 - PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2020-06-23),

14. 10603275 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2020-03-31),

15. 10227403 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2019-03-12),

Title: Inventor Spotlight: Radhika Korupolu - Transforming Drug Delivery Innovations

Introduction:

Radhika Korupolu is a trailblazing inventor based in San Jose, CA, known for her groundbreaking work in drug delivery technologies. With an impressive portfolio of 19 patents, Radhika is pushing boundaries in the medical field, particularly in the delivery of therapeutic agents within the gastrointestinal (GI) tract.

Latest Patents:

Radhika's latest patents showcase her innovative approach to drug delivery. Her inventions include swallowable drug delivery devices for PCSK9 antibody preparations and clotting factor preparations. These inventions aim to deliver therapeutic agents effectively within the GI tract, addressing conditions like cholesterol, lipid imbalances, and clotting disorders such as hemophilia.

Career Highlights:

Throughout her career, Radhika Korupolu has been associated with esteemed companies like Incube Labs, LLC and Rani Therapeutics, LLC. Her contributions to these organizations have been instrumental in advancing drug delivery technologies, improving patient outcomes, and revolutionizing the field of medicine.

Collaborations:

Radhika has collaborated with notable figures in the industry, including Mir Imran and Mir Hashim. These partnerships have led to the development of innovative solutions and have garnered recognition for their impactful contributions to the healthcare sector.

Conclusion:

Radhika Korupolu's ingenuity and dedication to revolutionizing drug delivery systems have established her as a prominent figure in the world of medical innovations. Her patents not only reflect her commitment to improving patient care but also highlight her relentless pursuit of excellence in the field of healthcare technology. Radhika's work continues to inspire and pave the way for future advancements in the industry.

Profile summary based on public USPTO records.